Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns.
prescribed semaglutide were more than four times more likely to be diagnosed with NAION, researchers reported July 3 in the journalhas exploded throughout industrialized countries and they have provided very significant benefits in many ways, but future discussions between a patient and their physician should include NAION as a potential risk," said lead researcher Dr. Joseph Rizzo, director of the Neuro-Ophthalmology Service at Mass Eye and Ear in Boston.
However, NAION is relatively rare, occurring in about 10 out of every 100,000 people, researchers said. For the study, researchers analyzed records for more than 17,000 Mass Eye and Ear patients treated during the six years since Ozempic was approved for"Our findings should be viewed as being significant but tentative, as future studies are needed to examine these questions in a much larger and more diverse population,” Rizzo said.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Forget Ozempic and Wegovy — Utahns embracing natural solution to boost GLP-1Given the potential side effects of GLP-1 prescription drugs, many Utahns are seeking alternative methods to naturally boost GLP-1 levels in the body.
Read more »
Weight Loss Drugs Like Wegovy and Ozempic May Influence How Food Tastes, Study FindsIn 'An Oprah Special: Shame, Blame and the Weight Loss Revolution,' Oprah talks obesity and weight loss drugs.
Read more »
Ozempic, Wegovy scams skyrocket as demand surges for expensive weight loss drugsScams targeting weight loss-related drugs such as Ozempic and Wegovy have proliferated, putting consumers who are seeking to purchase the medication at serious risk.
Read more »
Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefitsThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »
Non-Diabetic Use Of GLP-1 Drugs Like Ozempic For Weight Loss Affecting Retail Sizing CurvesI've been a journalist for 30 years, as a senior editor at W magazine, and for the last 17 years, covering retail and real estate as a senior editor at WWD. I write about luxury boutiques, independent retailers, department stores, mass chains, and digitally native brands, and the force that's redefining the way we shop – Amazon.
Read more »
Ozempic and Other GLP-1 Drugs May Cut Cancer RiskNew research suggests GLP-1 drugs like Ozempic can help prevent up to 10 different obesity-related cancers in people with type 2 diabetes.
Read more »